Cargando…

ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism

Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Hanxun, Hu, Zenan, Hu, Rui, Guo, Zeying, Zheng, Ya, Wang, Yuping, Zhou, Yongning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256994/
https://www.ncbi.nlm.nih.gov/pubmed/35814382
http://dx.doi.org/10.3389/fonc.2022.918778
_version_ 1784741238057992192
author Yue, Hanxun
Hu, Zenan
Hu, Rui
Guo, Zeying
Zheng, Ya
Wang, Yuping
Zhou, Yongning
author_facet Yue, Hanxun
Hu, Zenan
Hu, Rui
Guo, Zeying
Zheng, Ya
Wang, Yuping
Zhou, Yongning
author_sort Yue, Hanxun
collection PubMed
description Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies and found that ALDH1A1 could induce cancers via the maintenance of cancer stem cell properties, modification of metabolism, promotion of DNA repair. ALDH1A1 expression is regulated by several epigenetic processes. ALDH1A1 also acted as a tumor suppressor in certain cancers. The detoxification of ALDH1A1 often causes chemotherapy failure. Currently, ALDH1A1-targeted therapy is widely used in cancer treatment, but the mechanism by which ALDH1A1 regulates cancer development is not fully understood. This review will provide insight into the status of ALDH1A1 research and new viewpoint for cancer therapy.
format Online
Article
Text
id pubmed-9256994
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92569942022-07-07 ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism Yue, Hanxun Hu, Zenan Hu, Rui Guo, Zeying Zheng, Ya Wang, Yuping Zhou, Yongning Front Oncol Oncology Aldehyde dehydrogenases 1 family member A1(ALDH1A1) gene codes a cytoplasmic enzyme and shows vital physiological and pathophysiological functions in many areas. ALDH1A1 plays important roles in various diseases, especially in cancers. We reviewed and summarized representative correlative studies and found that ALDH1A1 could induce cancers via the maintenance of cancer stem cell properties, modification of metabolism, promotion of DNA repair. ALDH1A1 expression is regulated by several epigenetic processes. ALDH1A1 also acted as a tumor suppressor in certain cancers. The detoxification of ALDH1A1 often causes chemotherapy failure. Currently, ALDH1A1-targeted therapy is widely used in cancer treatment, but the mechanism by which ALDH1A1 regulates cancer development is not fully understood. This review will provide insight into the status of ALDH1A1 research and new viewpoint for cancer therapy. Frontiers Media S.A. 2022-06-22 /pmc/articles/PMC9256994/ /pubmed/35814382 http://dx.doi.org/10.3389/fonc.2022.918778 Text en Copyright © 2022 Yue, Hu, Hu, Guo, Zheng, Wang and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yue, Hanxun
Hu, Zenan
Hu, Rui
Guo, Zeying
Zheng, Ya
Wang, Yuping
Zhou, Yongning
ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism
title ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism
title_full ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism
title_fullStr ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism
title_full_unstemmed ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism
title_short ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism
title_sort aldh1a1 in cancers: bidirectional function, drug resistance, and regulatory mechanism
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256994/
https://www.ncbi.nlm.nih.gov/pubmed/35814382
http://dx.doi.org/10.3389/fonc.2022.918778
work_keys_str_mv AT yuehanxun aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism
AT huzenan aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism
AT hurui aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism
AT guozeying aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism
AT zhengya aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism
AT wangyuping aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism
AT zhouyongning aldh1a1incancersbidirectionalfunctiondrugresistanceandregulatorymechanism